Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M213Revenue $M0.5Net Margin (%)0Z-Score30.1
Enterprise Value $M168EPS $-0.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %-3.5Quick Ratio19.4Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-15.9Current Ratio19.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-53.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-63.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M67.2ROI % (ttm)-93.3Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CPRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Miller SteveCOO 2014-06-04Buy100,000$2.1754.38 view
MCENANY PATRICK JPresident and CEO 2014-05-21Buy25,000$1.8977.25 view
O'Keeffe Charles BDirector 2014-05-19Buy10,000$1.8383.06 view
O'Keeffe Charles BDirector 2014-04-16Buy5,000$2.0265.84 view
MCENANY PATRICK JPresident and CEO 2014-02-07Buy25,000$1.8284.07 view
O'Keeffe Charles BDirector 2014-02-05Buy10,000$1.8185.08 view
Tierney David SDirector 2013-10-23Buy8,000$2.0365.02 view
O'Keeffe Charles BDirector 2013-10-21Buy10,000$1.8482.07 view
MCENANY PATRICK JPresident and CEO 2013-10-21Buy50,000$1.59110.69 view
MCENANY PATRICK JPresident and CEO 2013-02-19Buy50,000$0.46628.26 view

Press Releases about CPRX :

    Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 25,000 Shares Nov 16 2009 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 12 2009 
    Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results Aug 07 2009 

    More From Our Partners
    Morning Market Movers Sep 30 2014 - BENZINGA

    More From Other Websites
    Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug Sep 30 2014
    Ford slips on Europe woes, Cintas, Synnex up on earnings Sep 29 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 29 2014
    Catalyst Pharma's lead drug succeeds in late-stage study Sep 29 2014
    Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical... Sep 29 2014
    4:00 pm Catalyst Pharma trading halted, news pending Sep 29 2014
    Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% Sep 05 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 04 2014
    Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development Sep 04 2014
    Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment... Sep 03 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 02 2014
    Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 Sep 02 2014
    Why Catalyst Pharmaceutical (CPRX) Could Be Positioned for a Surge? Aug 28 2014
    Your September Biotech Back-to-School Calendar Aug 26 2014
    Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Aug 26 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Financials Aug 22 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Aug 14 2014
    Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results Aug 14 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report Aug 13 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Aug 11 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK